Comparison of Aqueous Flare Values after Micropulse Transscleral Laser Treatment and Continuous Wave Transscleral Cyclophotocoagulation
- PMID: 35522198
- DOI: 10.1080/09273948.2022.2042315
Comparison of Aqueous Flare Values after Micropulse Transscleral Laser Treatment and Continuous Wave Transscleral Cyclophotocoagulation
Abstract
Purpose: The purpose of this study was to analyse the changes in flare values after Micropulse Transscleral Laser Treatment for Glaucoma (MP-TLT) in patients with refractory glaucoma and to compare with the outcomes of patients who underwent continuous wave (CW) diode laser cyclophotocoagulation (CW-TSCPC).
Methods: In this single-centre study, we reviewed the medical records of 54 patients who underwent MP-TLT and 35 patients who underwent CW-TSCPC at Ankara University Faculty of Medicine, Department of Ophthalmology. Aqueous flare values were measured by laser flare photometry.
Results: The mean laser flare values in both groups (MP-TLT/CW-TSCPC) increased after surgery from 20.85 ± 8.74/22.14 ± 7.39 ph/ms at baseline to 48.52 ± 18.23/57.38 ± 20.08 ph/ms (P = .001) on day 1 and then progressively decreased to 44.13 ± 18.32/52.24 ± 20.56 in week 1, 40.5 ± 18.5/48.24 ± 19.23 week 2 and 35.28 ± 17.09/41.11 ± 16.7 month 1 (all p < .05) and returned to similar levels to baseline at month 3 and month 6 (both p > .05). Patients who achieved treatment success had significantly higher flare values than patients who failed on post-operative day 1, week 1 and week 2 in both groups. The flare values were significantly lower in the MP-TLT group than the CW-TSCPC group on post-operative day 1, week 1, week 2 and month 1 (all p < .05). There were no cases of prolonged post-operative inflammation or serious complications in both groups.
Conclusion: Intraocular inflammation, quantified by aqueous flare, may be a contributing factor to the IOP lowering effect of transscleral diode laser cyclophotocoagulation in the early post-operative period.
Keywords: Aqueous flare; continuous wave; micropulse laser; transscleral diode cyclophotocoagulation.
Similar articles
-
An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma.Acta Ophthalmol. 2021 Aug;99(5):e621-e653. doi: 10.1111/aos.14661. Epub 2020 Nov 22. Acta Ophthalmol. 2021. PMID: 33222409 Review.
-
Micropulse Transscleral Laser Treatment Versus Continuous Wave Transscleral Cyclophotocoagulation for the Treatment of Glaucoma or Ocular Hypertension: A Meta-Analysis.J Glaucoma. 2025 Aug 1;34(8):575-584. doi: 10.1097/IJG.0000000000002583. Epub 2025 Apr 29. J Glaucoma. 2025. PMID: 40293349
-
Micropulse transscleral cyclophotocoagulation versus slow coagulation in refractory glaucoma: study protocol of a randomized clinical trial.Trials. 2025 Jun 4;26(1):192. doi: 10.1186/s13063-025-08907-6. Trials. 2025. PMID: 40468395 Free PMC article.
-
Outcomes of a combination of augmented MicroPulse and limited Continuous Wave Cyclophotocoagulation in patients with refractory glaucoma.Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1583-1592. doi: 10.1007/s00417-021-05436-1. Epub 2021 Oct 25. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34694455 Free PMC article.
-
Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction.Eur J Ophthalmol. 2021 Jan;31(1):112-119. doi: 10.1177/1120672119877586. Epub 2019 Sep 23. Eur J Ophthalmol. 2021. PMID: 31544505
Cited by
-
Comparison of treatment outcomes between slow coagulation transscleral cyclophotocoagulation and micropulse transscleral laser treatment.Sci Rep. 2024 Oct 13;14(1):23944. doi: 10.1038/s41598-024-75246-y. Sci Rep. 2024. PMID: 39397105 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical